Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 987-992, September 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hakala, M. T.
Right arrow Articles by Ishihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hakala, M. T.
Right arrow Articles by Ishihara, T.

Chromosomal Constitution and Amethopterin Resistance in Cultured Mouse Cells*

Maire T. Hakala and Takaaki Ishihara

( Departments of Experimental Therapeutics and Medicine C, Roswell Park Memorial Institute, Buffalo, New York)

The chromosomal constitutions of four amethopterin-resistant sublines of cultured Sarcoma 180 cells were compared with those of two sensitive sublines. No correlation between amethopterin resistance and chromosomes was observed. The chromosomal character of a resistant subline was completely retained in the sensitive subline derived from it after 9 months of continuous cultivation in the absence of the drug. The folic acid reductase content increased with increasing resistance and was 300–400 times higher in the 3000-fold resistant cell line than in the sensitive parent cells. Extensive selection is shown to be involved in the development of the amethopterin-resistant cell lines. This selection is most probably based on the capacity of a cell to rapidly increase the content of folic acid reductase.

* This investigation was supported in part by research grants (CY-4175 and CS-9749) from the National Cancer Institute of the United States Public Health Service.

Received 4/ 9/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.